The Use of Paclitaxel and Cisplatin in a Patient with Epithelial Ovarian Cancer and Human Immunodeficiency Virus

By Knox S.N.   Robinson J.B.   Im D.D.   Logan L.   Rosenshein N.B.  

Gynecologic Oncology, Vol. 76, Iss. 1, 2000-01 ,pp. : 118-122

Elsevier

Access to resources Recommend Favorite

Cisplatin-Paclitaxel-Cyclophosphamide with G-CSF in Primary Advanced Epithelial Ovarian Cancer

By Fanning J.   Colgrove M.   Phibbs G.  

Gynecologic Oncology, Vol. 79, Iss. 1, 2000-10 ,pp. : 97-100

Elsevier

Access to resources Recommend Favorite

Cost-Utility Analysis of Paclitaxel in Combination with Cisplatin for Patients with Advanced Ovarian Cancer

By Ortega A.   Dranitsaris G.   Sturgeon J.   Sutherland H.   Oza A.  

Gynecologic Oncology, Vol. 66, Iss. 3, 1997-09 ,pp. : 454-463

Elsevier

Access to resources Recommend Favorite

Results of Reinduction Therapy with Paclitaxel and Carboplatin in Recurrent Epithelial Ovarian Cancer

By Gronlund B.   Hogdall C.   Hansen H.H.   Engelholm S.A.  

Gynecologic Oncology, Vol. 83, Iss. 1, 2001-10 ,pp. : 128-134

Elsevier

Access to resources Recommend Favorite

Increased paclitaxel resistance in recurrent epithelial ovarian cancer: analysis of metachronous tumors

By Matsuo Koji   Im Dwight   Rosenshein Neil  

International Journal of Clinical Oncology, Vol. 15, Iss. 3, 2010-06 ,pp. : 325-327

Springer Publishing Company

Access to resources Recommend Favorite